JEITO
Created in 2017
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
312 783 6,604Entity types
Location
2 Rue Pillet-Will, 75009 Paris, France
Paris
France
Employees
Scale: 11-50
Estimated: 38
SIREN
982185035Engaged corporates
45
12 38Added in Motherbase
3 years, 3 months ago
Incubators & VCs Value proposition
Go faster for the Patient, further with the Entrepreneur
Jeito is a next-generation fund with a patient benefit driven approach, that focuses both on financing ground-breaking medical innovation and promoting positive societal impact. We empower and support entrepreneurs through our expert, integrated, multi-talented team.
Jeito Capital is based in Paris with a presence in Europe and the United States.
Follow us to get our latest news & job offers.
Private equity and BiopharmaOriginal language
Go faster for the Patient, further with the Entrepreneur
Jeito is a next-generation fund with a patient benefit driven approach, that focuses both on financing ground-breaking medical innovation and promoting positive societal impact. We empower and support entrepreneurs through our expert, integrated, multi-talented team.
Jeito Capital is based in Paris with a presence in Europe and the United States.
Follow us to get our latest news & job offers.
Un effort axé sur les avantages pour le patient
Jeito est un fonds biotechnologique de nouvelle génération dont l'approche est axée sur les avantages pour les patients et qui se concentre à la fois sur le financement d'innovations médicales révolutionnaires et sur la promotion d'un impact sociétal positif.
https://www.jeito.life/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 J.P. Morgan Bank | J.P. Morgan Bank | Other 12 Jan 2024 | | |
 Gustave Roussy Health, Hospitals and Health Care | Gustave Roussy Health, Hospitals and Health Care | Other 12 Jul 2024 | | |
 Dassault Systèmes IT services, Software Development | Dassault Systèmes IT services, Software Development | Other 12 Jul 2024 | | |
 Biogen Biotechnology, Biotechnology Research | Biogen Biotechnology, Biotechnology Research | Other 30 Jun 2024 | | |
 Celgene Pharmaceutical, Pharmaceutical Manufacturing | Celgene Pharmaceutical, Pharmaceutical Manufacturing | Other 5 Jan 2024 | | |
 Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 5 Jan 2024 | | |
 Ipsen Pharmaceutical, Pharmaceutical Manufacturing | Ipsen Pharmaceutical, Pharmaceutical Manufacturing | Other 16 Jan 2024 | | |
 Direction Générale des Entreprises National and local authorities, Government Administration | Direction Générale des Entreprises National and local authorities, Government Administration | Other 15 Nov 2023 | | |
 Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Other 7 Dec 2023 | | |
 Gilead Sciences Pharmaceutical, Biotechnology, Biotechnology Research | Gilead Sciences Pharmaceutical, Biotechnology, Biotechnology Research | Other 21 Apr 2023 | | |